IL-2Rγ CRISPR Activation Plasmid (h): sc-401876-ACT
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- IL-2Rγ CRISPR Activation Plasmid (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- IL-2Rγ CRISPR Activation Plasmid (h) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- gRNAs encoded by IL-2Rγ CRISPR Activation Plasmid (h) and IL-2Rγ CRISPR Activation Plasmid (h2) target distinct regulatory regions upstream of the IL2RG transcriptional start site. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: IL-2Rγ Antibody (A-10): sc-271060
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
IL-2Rγ CRISPR Activation Plasmid (h) | sc-401876-ACT | 20 µg | $397.00 |
IL2RG encodes the common gamma chain (IL-2Rγ, CD132), a shared signaling subunit for multiple cytokine receptors including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Upon cytokine engagement, IL-2Rγ cooperates with partner receptor chains to trigger JAK1/JAK3 activation and downstream STAT signaling, coordinating lymphocyte development, survival, and effector differentiation. This pathway is central to T cell, NK cell, and B cell biology and shapes broader immune homeostasis through cytokine-responsive transcriptional programs. Disruption or dysregulation of IL2RG-associated signaling is linked to profound immunodeficiency phenotypes and provides a tractable axis for studying cytokine network dependencies in human immune cells.
IL-2Rγ CRISPR Activation Plasmid (h) provides a targeted, non-destructive approach to upregulating endogenous IL2RG expression without altering the underlying DNA sequence.
IL-2Rγ CRISPR Activation Plasmid (h) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the IL2RG locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the IL2RG transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous IL-2Rγ expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native IL2RG locus and enabling the study of IL-2Rγ-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of IL-2Rγ pathway restoration in tumor cells with silenced or reduced IL2RG expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.